Published in Antimicrob Agents Chemother on April 01, 1994
Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother (2004) 1.11
Antiretroviral bioanalysis methods of tissues and body biofluids. Bioanalysis (2013) 0.94
In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.88
Implications of gender and pregnancy for antiretroviral drug dosing. Curr Opin HIV AIDS (2008) 0.80
Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques. Antimicrob Agents Chemother (1994) 0.79
Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother (1995) 0.78
Ex vivo human placental transfer of anti-human immunodeficiency virus compounds. Infect Dis Obstet Gynecol (1997) 0.75
Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.75
Zidovudine does not affect transplacental transfer or systemic clearance of stavudine (2',3'-didehydro-3'-deoxythymidine) in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.75
Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses. Drug Metab Dispos (2017) 0.75
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. Proc Natl Acad Sci U S A (1986) 6.63
Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity. Biochem Pharmacol (1987) 2.10
Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science (1992) 2.01
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther (1991) 1.58
3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J Biol Chem (1987) 1.32
Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection. J Med Primatol (1991) 1.07
Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J Acquir Immune Defic Syndr (1990) 1.05
Alternatives to chronic restraint of nonhuman primates. J Am Vet Med Assoc (1987) 1.04
The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol (1992) 1.01
Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration. J Acquir Immune Defic Syndr (1992) 0.98
Antiviral nucleoside toxicity in canine bone marrow progenitor cells and its relationship to drug permeation. Eur J Haematol (1992) 0.89
Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapy. Proc Natl Acad Sci U S A (1988) 0.87
Transfer and metabolism of dideoxyinosine by the perfused human placenta. J Acquir Immune Defic Syndr (1993) 0.86
2',3'-Dideoxyinosine is not metabolized in human placenta. Drug Metab Dispos (1993) 0.85
The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit. Drug Metab Dispos (1982) 0.84
3'-azido-3'-deoxythymidine and acyclovir: antiviral nucleoside analogues with unusual cell membrane permeation properties. Adv Exp Med Biol (1989) 0.82
The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm Res (1989) 0.82
Pharmacokinetics of clearance in the maternal-fetal amniotic fluid system of the rat. Toxicol Appl Pharmacol (1988) 0.78
Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial. Lancet (2002) 3.09
Trends in rates and seasonal distribution of sudden infant deaths in England and Wales, 1988-92. BMJ (1995) 2.47
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
Clinical pharmacokinetics of zidovudine. An overview of current data. Clin Pharmacokinet (1989) 1.52
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther (2009) 1.48
Redesigning postnatal care: a randomised controlled trial of protocol-based midwifery-led care focused on individual women's physical and psychological health needs. Health Technol Assess (2003) 1.45
Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin Pharmacol Ther (1986) 1.26
In vitro fertilization and embryo transfer in the rhesus monkey. Biol Reprod (1989) 1.23
Expression of arylamine N-acetyltransferase in human intestine. Gut (1998) 1.16
Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter. Pharm Res (1998) 1.15
Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos (1998) 1.14
Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate. J Acquir Immune Defic Syndr (1990) 1.11
Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). Endocrinology (1991) 1.08
Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. Clin Pharmacol Ther (2010) 1.08
Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J Acquir Immune Defic Syndr (1990) 1.05
Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol (1991) 1.05
Comparison of different regimens of human gonadotropins for superovulation of rhesus monkeys: ovulatory response and subsequent luteal function. J In Vitro Fert Embryo Transf (1989) 1.04
Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol (2004) 1.02
A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction. CPT Pharmacometrics Syst Pharmacol (2012) 1.02
Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology (2001) 1.01
Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. Biochem Pharmacol (1995) 1.00
Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration. J Acquir Immune Defic Syndr (1992) 0.98
Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys. Endocrinology (1988) 0.93
Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide. Anesth Analg (1986) 0.92
Metabolism of 3'-azido-3'-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells. Biochem Pharmacol (1994) 0.91
Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy. J Acquir Immune Defic Syndr (1991) 0.91
Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study. J Infect Dis (1999) 0.90
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther (1995) 0.89
CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos (2000) 0.89
Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina. Pharm Res (1994) 0.89
In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.88
Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim. Clin Pharmacol Ther (1991) 0.87
Ontogenic and longitudinal activity of Na(+)-nucleoside transporters in the human intestine. Am J Physiol Gastrointest Liver Physiol (2001) 0.86
Sodium-dependent nucleoside transport in the human intestinal brush-border membrane. Am J Physiol (1997) 0.86
Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate. Br J Pharmacol (2009) 0.85
Functional expression of human intestinal Na+-dependent and Na+-independent nucleoside transporters in Xenopus laevis oocytes. Biochem Pharmacol (1997) 0.85
In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol (1999) 0.85
In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens. J Pharmacol Exp Ther (1998) 0.84
Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs. Drug Metab Dispos (1995) 0.84
Effect of age on distribution of zidovudine (azidothymidine) into the cerebrospinal fluid of Macaca nemestrina. Pharm Res (1993) 0.83
Reflections on the knowledge base for obstetric fistula. Int J Gynaecol Obstet (2007) 0.83
Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. J Clin Endocrinol Metab (1993) 0.83
Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin. Clin Pharmacol Ther (1993) 0.83
Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.82
Disposition of drugs in cystic fibrosis. II. Hepatic blood flow. Clin Pharmacol Ther (1991) 0.82
The extent of metabolism of inhaled anesthetics in humans. Anesthesiology (1986) 0.82
Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells. Antimicrob Agents Chemother (1994) 0.82
Enzymes in addition to CYP3A4 and 3A5 mediate N-demethylation of dextromethorphan in human liver microsomes. Biopharm Drug Dispos (1999) 0.81
The effects of gonadectomy and testosterone treatment on luteinizing hormone secretion in fetal rhesus monkeys. Endocrinology (1982) 0.81
Structure-inhibitory profiles of nucleosides for the human intestinal N1 and N2 Na+-nucleoside transporters. Cancer Chemother Pharmacol (2000) 0.81
Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles. Cancer Chemother Pharmacol (2000) 0.81
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers. Clin Pharmacol Ther (1996) 0.81
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. Antimicrob Agents Chemother (1999) 0.80
CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit. Biopharm Drug Dispos (2001) 0.79
The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs. Clin Pharmacol Ther (2015) 0.79
Fetal, infant, and maternal toxicity of zidovudine (azidothymidine) administered throughout pregnancy in Macaca nemestrina. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.79
Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques. Antimicrob Agents Chemother (1994) 0.79
Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit. Drug Metab Dispos (1985) 0.78
Grapefruit juice, a glass full of drug interactions? Clin Pharmacol Ther (2007) 0.78
Different prolactin, thyrotropin, and thyroxine responses after prolonged intermittent or continuous infusions of thyrotropin-releasing hormone in rhesus monkeys. J Clin Endocrinol Metab (1983) 0.78
Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother (1995) 0.78
Nonlinear elimination and cholerteic effect of valproic acid in the monkey. J Pharmacol Exp Ther (1980) 0.78
Disposition of drugs in cystic fibrosis. VII. Acetylation of sulfamethoxazole in blood cells: in vitro-in vivo correlation and characterization of its kinetics of acetylation in lymphocytes. Clin Pharmacol Ther (1994) 0.78
Evidence for autonomous pituitary-adrenal function in the near-term fetal rhesus (Macaca mulatta). Endocrinology (1972) 0.78
Effect of pregnancy, mode of administration and neonatal age on the pharmacokinetics of zalcitabine (2', 3'-dideoxycytidine) in the pigtailed macaque (Macaca nemestrina). J Antimicrob Chemother (1997) 0.78
Development of a chronically catheterized maternal-fetal macaque model to study in utero mother-to-fetus HIV transmission: a preliminary report. J Med Primatol (1996) 0.77
Fetal toxicity of zidovudine (azidothymidine) in Macaca nemestrina: preliminary observations. J Acquir Immune Defic Syndr (1994) 0.77
Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrina. Am J Obstet Gynecol (1996) 0.76
Age affects the pharmacokinetics of inhaled anesthetics in humans. Anesth Analg (1991) 0.76
Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans? Anesth Analg (1987) 0.76
Zidovudine does not affect transplacental transfer or systemic clearance of stavudine (2',3'-didehydro-3'-deoxythymidine) in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.75
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 0.75
Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina). Antimicrob Agents Chemother (1995) 0.75
Endogenous opiate systems and primate reproduction: inability of naloxone to induce sexual activity in rhesus males. Arch Sex Behav (1982) 0.75
Acceptable sampling times at plateau for drug analysis. Br J Clin Pharmacol (1981) 0.75
Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother (1996) 0.75
The effect of fetal hypophysectomy on placental biosynthesis of progesterone in rhesus. Endocrinology (1975) 0.75
Dopamine: effects on prolactin and luteinizing hormone secretion in ovariectomized rhesus macaques after transection of the pituitary stalk. Neuroendocrinology (1981) 0.75
Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin. J Pharm Pharmacol (1984) 0.75
Suppression of maternal virus load with zidovudine, didanosine, and indinavir combination therapy prevents mother-to-fetus HIV transmission in macaques. J Acquir Immune Defic Syndr (2000) 0.75
Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosis. Clin Pharmacol Ther (1993) 0.75